Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Columba Quigley

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Cochrane Database of Systematic Reviews|October 29, 2013
WITHDRAWN: Hydromorphone for acute and chronic painColumba Quigley
BMJ Clinical Evidence|May 19, 2009
Opioids in people with cancer-related painColumba Quigley
The Cochrane Database of Systematic Reviews|October 22, 2013
WITHDRAWN: Opioid switching to improve pain relief and drug tolerabilityColumba Quigley
BMJ (Clinical Research Ed.)|October 8, 2005
The role of opioids in cancer painColumba Quigley
Journal of Pain and Symptom Management|February 19, 2003
A systematic review of hydromorphone in acute and chronic painColumba Quigley, Phil Wiffen
European Journal of Pain (London, England)|August 26, 2003
Transdermal fentanyl: informed prescribing is essentialJoy R Ross, Columba Quigley
Journal of Opioid Management|February 23, 2008
Prescribing opioids in renal failureJoanne Droney, Jeremy Levy, Columba Quigley
Palliative Medicine|June 26, 2003
Symptoms in 400 patients referred to palliative care services: prevalence and patternsJean Potter, Faeqa Hami, Tamsin Bryan, et al.
The Oncologist|August 2, 2006
Clinical pharmacology and pharmacotherapy of opioid switching in cancer patientsJoy R Ross, Julia Riley, Columba Quigley, et al.
Palliative Medicine|April 19, 2003
Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related painColumba Quigley, Simon Joel, Naina Patel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|October 29, 2013
WITHDRAWN: Hydromorphone for acute and chronic painColumba Quigley
BMJ Clinical Evidence|May 19, 2009
Opioids in people with cancer-related painColumba Quigley
The Cochrane Database of Systematic Reviews|October 22, 2013
WITHDRAWN: Opioid switching to improve pain relief and drug tolerabilityColumba Quigley
BMJ (Clinical Research Ed.)|October 8, 2005
The role of opioids in cancer painColumba Quigley
Journal of Pain and Symptom Management|February 19, 2003
A systematic review of hydromorphone in acute and chronic painColumba Quigley, Phil Wiffen
European Journal of Pain (London, England)|August 26, 2003
Transdermal fentanyl: informed prescribing is essentialJoy R Ross, Columba Quigley
Journal of Opioid Management|February 23, 2008
Prescribing opioids in renal failureJoanne Droney, Jeremy Levy, Columba Quigley
Palliative Medicine|June 26, 2003
Symptoms in 400 patients referred to palliative care services: prevalence and patternsJean Potter, Faeqa Hami, Tamsin Bryan, et al.
The Oncologist|August 2, 2006
Clinical pharmacology and pharmacotherapy of opioid switching in cancer patientsJoy R Ross, Julia Riley, Columba Quigley, et al.
Palliative Medicine|April 19, 2003
Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related painColumba Quigley, Simon Joel, Naina Patel, et al.
Pageof 2